These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 25200375)

  • 41. HHS issues final regulation on Medicare-endorsed Prescription Drug Card Initiative.
    Health Care Law Mon; 2002 Sep; ():13-5. PubMed ID: 12420392
    [No Abstract]   [Full Text] [Related]  

  • 42. 24th annual prescription survey, Albany College of Pharmacy.
    DeNuzzo RV
    Med Mark Media; 1980 Apr; 15(4):17-36. PubMed ID: 10245963
    [No Abstract]   [Full Text] [Related]  

  • 43. Prescription-drug coupons--no such thing as a free lunch.
    Ross JS; Kesselheim AS
    N Engl J Med; 2013 Sep; 369(13):1188-9. PubMed ID: 23984672
    [No Abstract]   [Full Text] [Related]  

  • 44. MNT essential to plans for adding prescription drug benefit to Medicare.
    Ketch TD
    J Am Diet Assoc; 2000 Jul; 100(7):762. PubMed ID: 10916511
    [No Abstract]   [Full Text] [Related]  

  • 45. Rx: Canadian drugs.
    Bugden S
    N Engl J Med; 2004 Mar; 350(11):1155. PubMed ID: 15014193
    [No Abstract]   [Full Text] [Related]  

  • 46. "Insuring" the continued solvency of pharmaceutical companies in the face of product liability class actions.
    Chodock R; Yolkut D; Connolly DR
    Tort Trial Insur Pract Law J; 2005; 40(3):997-1017. PubMed ID: 16100814
    [TBL] [Abstract][Full Text] [Related]  

  • 47. AMCP Guide to Pharmaceutical Payment Methods.
    AMCP Task Force on Drug Payment Methodologies
    J Manag Care Pharm; 2007 Oct; 13(8 Suppl C):S1-39. PubMed ID: 17970611
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gap in drug coverage often causes lapses in adherence to drug regimen, study shows.
    Levenson D
    Rep Med Guidel Outcomes Res; 2004 Sep; 15(18):9-10, 12. PubMed ID: 15452947
    [No Abstract]   [Full Text] [Related]  

  • 49. Prescription drug use continues to increase: U.S. prescription drug data for 2007-2008.
    Gu Q; Dillon CF; Burt VL
    NCHS Data Brief; 2010 Sep; (42):1-8. PubMed ID: 20854747
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmaceuticals: pharmaceutical cost controls--2005. End of Year Issue Brief.
    Seay M; Varma P
    Issue Brief Health Policy Track Serv; 2005 Dec; ():1-20. PubMed ID: 16708455
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
    Goedken AM; Urmie JM; Farris KB; Doucette WR
    Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Who are the players?
    Gordon JR; Maule CJ
    CPJ; 1989 Feb; 122(2):68-70, 72-3. PubMed ID: 10292086
    [No Abstract]   [Full Text] [Related]  

  • 53. PDP or MA-PD? Medicare part D enrollment decisions in CMS Region 25.
    Cline RR; Worley MM; Schondelmeyer SW; Schommer JC; Larson TA; Uden DL; Hadsall RS
    Res Social Adm Pharm; 2010 Jun; 6(2):130-42. PubMed ID: 20511112
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Drug consumption and drug compensation].
    Asbrink A
    Nord Med; 1970 Sep; 84(39):1249. PubMed ID: 5469311
    [No Abstract]   [Full Text] [Related]  

  • 55. [Prescription drug consumption recovery following the co-payment change: Evidence from a regional health service].
    Sánchez DP; Guillén JJ; Torres AM; Arense JJ; López Á; Sánchez FI
    Aten Primaria; 2015; 47(7):411-8. PubMed ID: 25500171
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The pharmaceutical industry's responsibilities in the prescription process.
    Tidball P
    Can Pharm J; 1981 May; 114(5):177-9. PubMed ID: 10251274
    [No Abstract]   [Full Text] [Related]  

  • 57. The impact of co-payment increases on dispensings of government-subsidised medicines in Australia.
    Hynd A; Roughead EE; Preen DB; Glover J; Bulsara M; Semmens J
    Pharmacoepidemiol Drug Saf; 2008 Nov; 17(11):1091-9. PubMed ID: 18942671
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Doctor pharmaceutical utilization behaviour changed by the global budget programme strategies on hypertensive outpatient prescription.
    Wei CK; Wang SM; Yeh MK
    J Eval Clin Pract; 2012 Apr; 18(2):262-8. PubMed ID: 21040251
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Social problem associated with drugs].
    Palenzona C
    Minerva Med; 1978 Jan; 69(4):271-4. PubMed ID: 625379
    [No Abstract]   [Full Text] [Related]  

  • 60. Quality of evidence in drug compendia supporting off-label use of typical and atypical antipsychotic medications.
    Paczynski RP; Alexander GC; Chinchilli VM; Kruszewski SP
    Int J Risk Saf Med; 2012 Jan; 24(3):137-46. PubMed ID: 22936056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.